01.05.2006 | Phase II Studies

Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

verfasst von: Emilio Esteban, MD, Joaquin Fra, Yolanda Fernández, Norberto Corral, José M. Vieitez, Isabel Palacio, José L. de Sande, José L. Fernández, Isabel Muñiz, Noemi Villanueva, Enrique Estrada, Beatriz Mareque, Esther Uña, José M. Buesa, Angel J. Lacave, on behalf of the Grupo Oncológico del Norte de España (“GON”)

Erschienen in: Investigational New Drugs | Ausgabe 3/2006